Evaluation of a Bioimpedance Method for Determination of Dry Weight in Dialysis Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-11-30

Study Completion Date

2008-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is the evaluation of a bioimpedance method for determination of dry weight in dialysis patients. Additionally normal tissue hydration in non-Dialysis patients is investigated in healthy subjects and patients with chronic kidney disease in stages K/DIGO I-IV

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bioimpedance Analysis for Hemodialysis

NCT06573567

Hemodialysis Complication

RECRUITING NA

Continuous Registration of Bioimpedance During Hemodialysis

NCT03990818

UNKNOWN

Study Comparing Dryweight Determination in Hemodialysis Patients With Two Methods

NCT02348996

Chronic Kidney Disease

COMPLETED NA

The Use of Electrical Bioimpedance to Evaluate Dry Weight in Patients With Chronic Renal Failure in Hemodialysis

NCT03232515

Chronic Renal Failure Dialysis Dry Weight +1 more

COMPLETED NA

BIS-guided Fluid Management in HD Patients

NCT05272800

Kidney Failure Haemodialysis Fluid Adverse Reaction

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Insufficiency, Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bioimpedance Analysis

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* clinically stable on dialysis within the last three months
* signed written informed consent

Exclusion Criteria

* acute myocardial infarction or stroke within the last six months
* heart failure stage NYHA IV
* concommitant participation in other interventional trials
* psychiatric conditions that prevent subject from following the study procedures / protocol
* pregnancy or lactation
* limb amputation
* cardiac pacemaker
* joint implants
* implantable pumps and other metallic implants

For healthy subjects and CKD patients in stages K/DIGO I-IV the above mentioned criteria other than the first mentioned are applicable respectively.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes